SHINE Medical Technologies (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- September 03, 2020
- Vertical
- Nuclear Technology
- Funding URL
- View Funding Page
- Funding Amount:
- $80,000,000
Company Info
- Founding Year
- 2010
- Traction
- In 2014, SHINE announced the execution of Mo-99 supply agreements with GE Healthcare and Lantheus Medical Imaging. In 2015, GE Healthcare demonstrated that SHINE Mo-99 can act as a drop-in replacement for reactor-based Mo-99.
- Organizations Involved
- GE Healthcare, Lantheus Medical Imaging
- Founders
- Greg Piefer
- Company Description
- SHINE is a nuclear technology company working to become the world's leading provider of radioisotopes for nuclear medicine. The SHINE system uses a patented, proprietary manufacturing process that offers major advantages over existing and proposed production technologies.
- Market
- Nuclear Medicine
- Location
- Janesville, WI, USA
- Coinvestors
- Fidelity Management & Research Company